After exclusion of these SNPs, the MR effect estimate of circulating CRP levels on prostate cancer risk did not change essentially (OR 1.04, 95% CI 0.91 to 1.19, and P = 0.54 using the IVW method; Supplementary Table 4). This evidence concerns the gene CRP and prostate cancer.